Claude Nicaise

Insider Reports History

Entity
Individual
Location
215 First Street, Suite 415, Cambridge, MA
Signature
/s/ Daniel Porco, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Claude Nicaise:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sarepta Therapeutics, Inc. Director Common Stock 18.2K $2.29M $126.19 Mar 1, 2024 Direct
CASSAVA SCIENCES INC Director Stock Option (Right to Buy) 10K $169K $16.87 May 9, 2024 Direct
Gain Therapeutics, Inc. Director Stock Option (right to buy) 15K Jun 24, 2024 Direct
Chemomab Therapeutics Ltd. Director Option to Purchase American Depositary Shares 11.9K Mar 16, 2023 Direct
Sarepta Therapeutics, Inc. Director Stock Option (right to buy) 3.68K Mar 1, 2024 Direct

Insider Reports Filed by Claude Nicaise

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GANX Gain Therapeutics, Inc. Jun 24, 2024 1 $0 4 Jun 26, 2024 Director
SAVA CASSAVA SCIENCES INC May 9, 2024 1 $0 4 May 13, 2024 Director
SRPT Sarepta Therapeutics, Inc. Mar 1, 2024 2 $0 4 Mar 5, 2024 Director
SAVA CASSAVA SCIENCES INC Dec 6, 2023 1 $0 4 Dec 8, 2023 Director
SAVA CASSAVA SCIENCES INC Dec 6, 2023 0 $0 3 Dec 8, 2023 Director
GANX Gain Therapeutics, Inc. Jun 23, 2023 1 $0 4 Jun 26, 2023 Director
CMMB Chemomab Therapeutics Ltd. Mar 16, 2023 3 $0 4 Mar 23, 2023 Director
SRPT Sarepta Therapeutics, Inc. Mar 6, 2023 2 $0 4 Mar 8, 2023 Director
GANX Gain Therapeutics, Inc. Sep 20, 2022 1 $0 4 Sep 22, 2022 Director
CMMB Chemomab Therapeutics Ltd. Mar 7, 2022 2 $0 4 Mar 9, 2022 Director
SRPT Sarepta Therapeutics, Inc. Mar 7, 2022 2 $0 4 Mar 8, 2022 Director